CANbridge Pharmaceuticals Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	66.63	10.5	137.49	463.11	745.82
Cash & Short-Term Investments	66.63	10.5	137.49	463.11	745.82
Cash Growth	534.40%	-92.36%	-70.31%	-37.91%	106.71%
Accounts Receivable	15.12	16.72	31.23	19.05	9.14
Other Receivables	-	9.87	8.29	-	18.76
Receivables	15.12	26.59	39.52	19.05	27.9
Inventory	20.57	7.9	8.78	9.82	13.45
Other Current Assets	7.86	0.36	24.08	13.18	24.54
Total Current Assets	110.17	45.35	209.86	505.16	811.71
Property, Plant & Equipment	0.51	3.64	109.01	144.72	29.54
Other Intangible Assets	54.71	67.82	76.49	49.01	51.27
Other Long-Term Assets	-	-	-	3.16	-
Total Assets	165.39	116.81	395.36	702.05	892.52
Accounts Payable	368.83	370.46	198.05	107.54	43.61
Accrued Expenses	-	68.7	63.46	114.98	93.82
Current Portion of Long-Term Debt	7.03	15.33	23.69	26.87	30.87
Current Portion of Leases	0.91	11.76	11.03	13.03	7.88
Current Unearned Revenue	2.73	-	-	-	-
Other Current Liabilities	75.84	16.37	31.71	15.69	9.6
Total Current Liabilities	455.34	482.61	327.95	278.11	185.78
Long-Term Debt	8	15.04	6.63	10.78	-
Long-Term Leases	0.14	93.65	100.58	104.61	13.35
Long-Term Unearned Revenue	43.66	-	-	-	-
Total Liabilities	507.15	591.3	435.15	393.49	199.13
Common Stock	0.03	0.03	0.03	0.03	0.03
Additional Paid-In Capital	-	3,474	3,473	3,471	3,471
Retained Earnings	-	-4,210	-3,789	-3,411	-2,927
Comprehensive Income & Other	-341.79	261.79	276.55	247.88	149.89
Shareholders' Equity	-341.76	-474.49	-39.79	308.56	693.39
Total Liabilities & Equity	165.39	116.81	395.36	702.05	892.52
Total Debt	16.08	135.78	141.93	155.28	52.1
Net Cash (Debt)	50.54	-125.28	-4.44	307.83	693.71
Net Cash Growth	-	-	-	-55.63%	-
Net Cash Per Share	0.11	-0.29	-0.01	0.73	7.36
Filing Date Shares Outstanding	482.31	424.56	424.56	424.29	424.19
Total Common Shares Outstanding	482.31	424.56	424.56	424.29	424.19
Working Capital	-345.17	-437.26	-118.08	227.06	625.93
Book Value Per Share	-0.71	-1.12	-0.09	0.73	1.63
Tangible Book Value	-396.47	-542.31	-116.28	259.54	642.12
Tangible Book Value Per Share	-0.82	-1.28	-0.27	0.61	1.51
Machinery	-	10.68	16.58	13.54	4.79
Leasehold Improvements	-	1.94	3.94	10.86	11.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.